Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Prescribing considerations: FDA-approved for short-term use (up to 12 weeks), though many obesity medicine specialists prescribe it for longer durations based on risk-benefit assessment
Nephron 1984;38(2):120-124
Always confirm the mg/mL concentration on the vial/label and follow clinic/pharmacy instructions, do not guess
Mximo 1 toma al da
Unlike many hypoglycemic drugs, GLP-1 regulates glucose levels in a glucose-dependent manner, significantly reducing the risk of hypoglycemia
US$ 22.08
US$ 26.53
US$ 21.27
US$ 20.77
US$ 24.81
US$ 25.25
